| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V0296 | BAY 87-2243 | 1227158-85-1 | BAY 87-2243 (BAY-87-2243) is a selective hypoxia-inducible factor-1 (HIF-1) inhibitor with potential anticancer activity. |
|
V0298 | FG-2216 (YM-311; IOX-3; YM-311) | 223387-75-5 | FG-2216 (YM311;IOX3; YM311) is a novel, potent, and orally bioactive inhibitor of hypoxia-inducible factor-1α (HIF) prolyl 4-hydroxylase (PHD) with the potential to treat anemia. |
|
V4797 | IDF-11774 | 1429054-28-3 | IDF-11774 (IDF11774) is a novel, potent, and orally bioavailable HIF-1α (hypoxia-inducible factor 1α) inhibitor with anticancer activity. |
|
V0295 | IOX2 | 931398-72-0 | IOX2 is a novel and potent inhibitor of hypoxia-inducible factor (HIF-1α) prolyl hydroxylase-2 (PHD2) with considerable medical uses. |
|
V2691 | MK-8617 | 1187990-87-9 | MK-8617 is a novel potent, selective, orally bioavailable pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1−3 (HIF PHD1−3), which inhibits PHD1, 2, 3 with IC50 values of 1.0, 1.0 and 14 nM, respectively. |
|
V13346 | PT2399 | 1672662-14-4 | PT2399 is a novel, potent, andorally bioavailable small molecule inhibitor of HIF-2 whichbinds to HIF-2α PAS B domain with an IC50 of 6 nM, exhibiting potent antitumor activity in vivo. |
|
V0293 | Roxadustat (FG-4592) | 808118-40-3 | Roxadustat (FG4592, ASP1517) is a novel, potent and orally bioavailable inhibitor of HIF-PH (hypoxia-inducible factor prolyl hydroxylase) with the potential to treat anemia associated with chronic kidney disease (CKD). |